Back to top

cannabis: Archive

Zacks Equity Research

GrowGeneration (GRWG) Q3 Earnings Miss, Revenues Dip Y/Y

GrowGeneration (GRWG) witnesses year-over-year decline in retail revenues, e-commerce revenues and non-retail operations in Q3.

ANDENegative Net Change CRSNegative Net Change USAPPositive Net Change GRWGNo Net Change

Zacks Equity Research

Jazz (JAZZ) Lags Q3 Earnings, Beats Sales, Raises '23 View

Jazz (JAZZ) reports mixed results in third-quarter 2023. However, shares rose 2.5% post the announcement, likely on the back of raised guidance for 2023.

JAZZPositive Net Change BHVNNegative Net Change CDMOPositive Net Change APLSPositive Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q3 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q3 performance, though high expenses might have played a spoilsport.

VTRNegative Net Change DEAPositive Net Change IIPRPositive Net Change

Neena Mishra

Cannabis Stocks & ETFs: Can the Recent Surge Continue?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

TLRYPositive Net Change CNBSPositive Net Change GTBIFPositive Net Change CURLFPositive Net Change

Brian Bolan

Cannabis Stocks Are Moving Higher

A looking into what is driving the recent spike in cannabis stocks.

TLRYPositive Net Change YOLOPositive Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q2 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q2 performance, though high expenses might have played a spoilsport.

VTRNegative Net Change IIPRPositive Net Change COLDPositive Net Change

Madhurima Das

4 Agriculture - Products Stocks to Watch in a Challenging Industry

Despite the Agriculture - Products industry facing elevated input costs and supply chain issues, stocks like Bunge (BG), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA) are poised well to withstand the same.

BGNegative Net Change RKDAPositive Net Change PHOTNegative Net Change GRWGNo Net Change HYFMNegative Net Change

Zacks Equity Research

GrowGeneration (GRWG) Buys Stores in Alaska to Boost Portfolio

GrowGeneration (GRWG) acquires two stores in Alaska, increasing the number of states it operates in to 18.

AUNegative Net Change GFINegative Net Change AGINegative Net Change GRWGNo Net Change

Zacks Equity Research

GrowGeneration (GRWG) Enters Mushroom Industry With GrowLife Deal

GrowGeneration (GRWG) forms an alliance with Bridgetown Mushrooms to sell Bridgetown's mycology products.

GFINegative Net Change AGINegative Net Change PHOTNegative Net Change GRWGNo Net Change

Zacks Equity Research

Innovative Industrial's (IIPR) Q1 Adjusted FFO Beats Estimates

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties aids its Q1 performance, though high expenses act as a spoilsport.

STAGNegative Net Change IIPRPositive Net Change VICIPositive Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q1 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q1 performance, though high expenses might have played a spoilsport.

AHHPositive Net Change IIPRPositive Net Change GRP.UPositive Net Change

Bryan Hayes

Pot Stocks Surge on SAFE Banking Act Reintroduction

Lawmakers are attempting to make a final push toward delivering financial services for the cannabis industry.

CGCPositive Net Change MSOSPositive Net Change GTBIFPositive Net Change

Bryan Hayes

Is Tilray Brands (TLRY) A Buy Ahead of Fiscal Q3 Earnings Announcement?

Industry headwinds still present a major challenge.

TLRYPositive Net Change

Zacks Equity Research

GrowGeneration (GRWG) Q4 Earnings Miss, Revenues Down Y/Y

GrowGeneration (GRWG) reports lower revenues and a loss per share of 25 cents for the fourth quarter of 2022 due to the ongoing weakness in the cannabis industry and efforts to lower its inventory.

STLDNegative Net Change NUEPositive Net Change ZEUSPositive Net Change GRWGNo Net Change

Zacks Equity Research

Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales

Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.

JAZZPositive Net Change AMRNNegative Net Change AXSMPositive Net Change ALLOPositive Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q4 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q4 performance, though high expenses might have played a spoilsport.

PSANegative Net Change EXRNegative Net Change IIPRPositive Net Change PSTLPositive Net Change

Andrew Rocco

Wednesday Recap: Minty Fresh Breadth

Breadth is an important measure used by investors to determine how strong or weak a market index is beneath the surface. Tuesday, the market flashed very strong breadth - an indication that bulls may be ready to take back the baton.

AAPLNegative Net Change MSFTNegative Net Change SINegative Net Change TSLAPositive Net Change BABANegative Net Change CGCPositive Net Change

Benjamin Rains

Marijuana Sales Are Soaring and the Sky's the Limit

Marijuana stocks were battered in 2022 along with all the other growth names, which means they're set for a big rebound. Ben Rains can get you prepared for a burgeoning space that grows more profitable and more legal every day.

AAPLNegative Net Change MSFTNegative Net Change SINegative Net Change TSLAPositive Net Change BABANegative Net Change CGCPositive Net Change

Benjamin Rains

The Booming Legal Cannabis Market Has Plenty of Upside

The state-by-state marijuana legalization wave continues to sweep the country and is gaining steam across all types of political and social leanings. Ben Rains says now is the time to get involved in this growing space, which should see U.S. sales soar past $30 billion this year.

AAPLNegative Net Change MSFTNegative Net Change SINegative Net Change TSLAPositive Net Change BABANegative Net Change CGCPositive Net Change

Zacks Equity Research

GrowGeneration (GRWG) Grows Base With 1st Store in New Jersey

GrowGeneration (GRWG) launches its first store in New Jersey to widen its reach to 16 states and further strengthen its operations.

NUEPositive Net Change BGNegative Net Change IOSPPositive Net Change GRWGNo Net Change

Zacks Equity Research

Aurora Cannabis (ACB) to Report Q1 Earnings: What's in Store?

Continued strength in Aurora Cannabis' (ACB) domestic adult recreational segment is expected to have driven Q1 sales.

AVEOPositive Net Change ACBPositive Net Change GDRXNegative Net Change

Zacks Equity Research

Key Factors to Impact Innovative Industrial (IIPR) Q3 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q3 performance, though high expenses might have played a spoilsport.

HSTNegative Net Change PSANegative Net Change EXRNegative Net Change IIPRPositive Net Change

Zacks Equity Research

GrowGeneration (GRWG) Opens 1st Hydroponic Store in Virginia

GrowGeneration (GRWG) opens a new store in Virginia and signs two new leases in New Jersey and Missouri, progressing well on its strategy to grow its retail presence across North America.

SMGPositive Net Change GRWGNo Net Change GTBIFPositive Net Change CRLBFPositive Net Change

Zacks Equity Research

GrowGeneration (GRWG) Q2 Earnings Miss, Lowers '22 View

GrowGeneration (GRWG) reports a drop in Q2 revenues due to the ongoing weakness in the cannabis industry. It lowers revenue guidance to $250 million and $275 million for 2022.

ALBPositive Net Change SQMPositive Net Change CBTNegative Net Change GRWGNo Net Change

Zacks Equity Research

Jazz's (JAZZ) Q2 Earnings Beat, New Drugs Post Robust Sales

JAZZ's Q2 earnings and sales beat expectations on strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. The company affirms its 2022 guidance.

LLYPositive Net Change JAZZPositive Net Change NVAXNegative Net Change AXSMPositive Net Change